Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- Autores
- Wong, Vincent Wai-Sun; Adams, Leon A.; de Lédinghen, Victor; Wong, Grace Lai-Hung; Sookoian, Silvia Cristina
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is the active form of NAFLD, with hepatic necroinflammation and faster fibrosis progression. With an increasing number of patients developing NASH-related end-stage liver disease and pharmacological treatments on the horizon, there is a pressing need to develop NAFLD and NASH biomarkers for prognostication, selection of patients for treatment and monitoring. This requirement is particularly true as liver biopsy utility is limited by its invasive nature, poor patient acceptability and sampling variability. This article reviews current and potential biomarkers for different features of NAFLD, namely, steatosis, necroinflammation and fibrosis. For each biomarker, we evaluate its accuracy, reproducibility, responsiveness, feasibility and limitations. We cover biochemical, imaging and genetic biomarkers and discuss biomarker discovery in the omics era.
Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong
Fil: Adams, Leon A.. University of Western Australia; Australia
Fil: de Lédinghen, Victor. Universite de Bordeaux; Francia
Fil: Wong, Grace Lai-Hung. Chinese University Of Hong Kong; Hong Kong
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina - Materia
-
NASH
NAFLD
BIOMARKERS
OMICS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR)
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/86757
Ver los metadatos del registro completo
id |
CONICETDig_eaccc187c6be2590d8c693d513bb9378 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/86757 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promiseWong, Vincent Wai-SunAdams, Leon A.de Lédinghen, VictorWong, Grace Lai-HungSookoian, Silvia CristinaNASHNAFLDBIOMARKERSOMICShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is the active form of NAFLD, with hepatic necroinflammation and faster fibrosis progression. With an increasing number of patients developing NASH-related end-stage liver disease and pharmacological treatments on the horizon, there is a pressing need to develop NAFLD and NASH biomarkers for prognostication, selection of patients for treatment and monitoring. This requirement is particularly true as liver biopsy utility is limited by its invasive nature, poor patient acceptability and sampling variability. This article reviews current and potential biomarkers for different features of NAFLD, namely, steatosis, necroinflammation and fibrosis. For each biomarker, we evaluate its accuracy, reproducibility, responsiveness, feasibility and limitations. We cover biochemical, imaging and genetic biomarkers and discuss biomarker discovery in the omics era.Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong KongFil: Adams, Leon A.. University of Western Australia; AustraliaFil: de Lédinghen, Victor. Universite de Bordeaux; FranciaFil: Wong, Grace Lai-Hung. Chinese University Of Hong Kong; Hong KongFil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaNature Publishing Group2018-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/86757Wong, Vincent Wai-Sun; Adams, Leon A.; de Lédinghen, Victor; Wong, Grace Lai-Hung; Sookoian, Silvia Cristina; Noninvasive biomarkers in NAFLD and NASH — current progress and future promise; Nature Publishing Group; Nature Reviews Gastroenterology & Hepatology; 15; 8; 8-2018; 461-4781759-5045CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41575-018-0014-9info:eu-repo/semantics/altIdentifier/doi/10.1038/s41575-018-0014-9info:eu-repo/semantics/openAccessAtribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR)https://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:44:05Zoai:ri.conicet.gov.ar:11336/86757instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:44:06.02CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
title |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
spellingShingle |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise Wong, Vincent Wai-Sun NASH NAFLD BIOMARKERS OMICS |
title_short |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
title_full |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
title_fullStr |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
title_full_unstemmed |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
title_sort |
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise |
dc.creator.none.fl_str_mv |
Wong, Vincent Wai-Sun Adams, Leon A. de Lédinghen, Victor Wong, Grace Lai-Hung Sookoian, Silvia Cristina |
author |
Wong, Vincent Wai-Sun |
author_facet |
Wong, Vincent Wai-Sun Adams, Leon A. de Lédinghen, Victor Wong, Grace Lai-Hung Sookoian, Silvia Cristina |
author_role |
author |
author2 |
Adams, Leon A. de Lédinghen, Victor Wong, Grace Lai-Hung Sookoian, Silvia Cristina |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
NASH NAFLD BIOMARKERS OMICS |
topic |
NASH NAFLD BIOMARKERS OMICS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is the active form of NAFLD, with hepatic necroinflammation and faster fibrosis progression. With an increasing number of patients developing NASH-related end-stage liver disease and pharmacological treatments on the horizon, there is a pressing need to develop NAFLD and NASH biomarkers for prognostication, selection of patients for treatment and monitoring. This requirement is particularly true as liver biopsy utility is limited by its invasive nature, poor patient acceptability and sampling variability. This article reviews current and potential biomarkers for different features of NAFLD, namely, steatosis, necroinflammation and fibrosis. For each biomarker, we evaluate its accuracy, reproducibility, responsiveness, feasibility and limitations. We cover biochemical, imaging and genetic biomarkers and discuss biomarker discovery in the omics era. Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong Fil: Adams, Leon A.. University of Western Australia; Australia Fil: de Lédinghen, Victor. Universite de Bordeaux; Francia Fil: Wong, Grace Lai-Hung. Chinese University Of Hong Kong; Hong Kong Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina |
description |
Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is the active form of NAFLD, with hepatic necroinflammation and faster fibrosis progression. With an increasing number of patients developing NASH-related end-stage liver disease and pharmacological treatments on the horizon, there is a pressing need to develop NAFLD and NASH biomarkers for prognostication, selection of patients for treatment and monitoring. This requirement is particularly true as liver biopsy utility is limited by its invasive nature, poor patient acceptability and sampling variability. This article reviews current and potential biomarkers for different features of NAFLD, namely, steatosis, necroinflammation and fibrosis. For each biomarker, we evaluate its accuracy, reproducibility, responsiveness, feasibility and limitations. We cover biochemical, imaging and genetic biomarkers and discuss biomarker discovery in the omics era. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/86757 Wong, Vincent Wai-Sun; Adams, Leon A.; de Lédinghen, Victor; Wong, Grace Lai-Hung; Sookoian, Silvia Cristina; Noninvasive biomarkers in NAFLD and NASH — current progress and future promise; Nature Publishing Group; Nature Reviews Gastroenterology & Hepatology; 15; 8; 8-2018; 461-478 1759-5045 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/86757 |
identifier_str_mv |
Wong, Vincent Wai-Sun; Adams, Leon A.; de Lédinghen, Victor; Wong, Grace Lai-Hung; Sookoian, Silvia Cristina; Noninvasive biomarkers in NAFLD and NASH — current progress and future promise; Nature Publishing Group; Nature Reviews Gastroenterology & Hepatology; 15; 8; 8-2018; 461-478 1759-5045 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.nature.com/articles/s41575-018-0014-9 info:eu-repo/semantics/altIdentifier/doi/10.1038/s41575-018-0014-9 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR) https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
Atribución-NoComercial-CompartirIgual 2.5 Argentina (CC BY-NC-SA 2.5 AR) https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268644602544128 |
score |
13.13397 |